FIELD: chemistry.
SUBSTANCE: disclosed is a single-chain multi-specific binding protein for binding or modulating activity of one or more biding partner molecules. The protein contains from the N-terminal to the C-terminal: a first binding domain derived from variable regions of a light and a heavy immunoglobulin chain; a constant sub-region derived from immunoglobulin containing a hinge or hinge-like domain, a CH2-domain and a CH3-domain; scorpion linker peptide, where said peptide contains an amino acid sequence from the immunoglobulin hinge or a type II C-lectin protein stalk region; and a second binding domain derived from variable regions of a light and a heavy immunoglobulin chain. The invention describes an encoding nucleic acid, as well as an expression vector based thereon and a host cell for vector based protein expression. The invention discloses a pharmaceutical composition for treating cell proliferation disorders based on a single-chain protein and a protein dimer for binding or modulating activity of one or more binding partner molecules based on two single-chain binding proteins.
EFFECT: invention provides multi-specific molecules which retain effector functions, insensitivity to proteolytic cleavage, and can be used in therapy of different diseases.
31 cl, 61 dwg, 14 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
CD37-IMMUNOTHERAPEUTIC COMBINATION THERAPY AND USING IT | 2009 |
|
RU2526156C2 |
IMMUNOTHERAPY OF MALIGNANT DISEASES OF B-CELLS AND AUTOIMMUNE DISEASES WITH APPLICATION OF CONJUGATE AND NONCONJUGATE ANTIBODIES, COMBINATIONS OF ANTIBODIES AND CONJOINT PROTEINS | 2003 |
|
RU2335297C2 |
MOLECULES WITH SPECIFICITY WITH RESPECT TO CD79 AND CD22 | 2015 |
|
RU2743590C2 |
DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2423381C2 |
PROTEINS BINDING SPECIFIC MEMBRANE PROSTATE ANTIGEN, AND RELATED COMPOSITIONS AND METHODS | 2012 |
|
RU2632647C2 |
IMMUNOGLOBULIN WITH DOUBLE VARIABLE DOMAINS AND ITS APPLICATIONS | 2006 |
|
RU2515108C2 |
POLYPEPTIDES BINDING TO CD3 | 2013 |
|
RU2673153C2 |
COMBINED THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES BY USING COMBINATION OF ELIMINATING B-CELLS AND IMMUNOREGULATORY ANTIBODIES | 2001 |
|
RU2285541C2 |
BISPECIFIC ASYMMETRIC HETERODIMERS COMPRISING ANTI-CD3 CONSTRUCTS | 2013 |
|
RU2650868C2 |
IMMUNOTHERAPEUTIC AGENT COMBINED WITH CD37, AND ITS COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC AGENT | 2009 |
|
RU2531754C2 |
Authors
Dates
2013-07-20—Published
2007-06-12—Filed